Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck.
暂无分享，去创建一个
J. Grandis | P. Harari | A. Argiris | F. Worden | M. Kies | G. Blumenschein | M. Gibson | R. Gyanchandani | A. Kotsakis | T. Hoang | S. Kim | P. Savvides | H. Chen | S. Kim | Francis P. Worden | Michael K. Gibson